Delirium Market Research Report: By Type (Hyperactive, Hypoactive, Mixed), Treatment (Antipsychotics, Supportive Care), Diagnosis (Laboratory Tests, Imaging Tests, Physical Examination), End-User (Hospitals, Specialty Centers) -Forecast Till 2027

Table of Content

1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Global Delirium Market, by Type

6.1 Introduction

6.2 Hyperactive

6.2.1 Market Estimates & Forecast, 2020–2027

6.3 Hypoactive

6.3.1 Market Estimates & Forecast, 2020–2027

6.4 Mixed

6.4.1 Market Estimates & Forecast, 2020–2027

7. Global Delirium Market, by Diagnosis

7.1 Introduction

7.2 Laboratory Tests

7.2.1 Blood Tests

7.2.2 Urine Tests

7.2.3 Market Estimates & Forecast, 2020–2027

7.3 Imaging Tests

7.3.1 Brain-imaging tests

7.3.2 Market Estimates & Forecast, 2020–2027

7.4 Physical Examination

7.4.1 Market Estimates & Forecast, 2020–2027

8. Global Delirium Market, by Treatment

8.1 Introduction

8.2 Antipsychotics

8.2.1 Risperidone

8.2.2 Olanzapine

8.2.3 Quetiapine

8.2.4 Market Estimates & Forecast, 2020–2027

8.3 Supportive Care

8.3.1 Market Estimates & Forecast, 2020–2027

9. Global Delirium Market, by End U.S.er

9.1 Introduction

9.2 Hospitals

9.2.1 Market Estimates & Forecast, 2020–2027

9.3 Specialty Centers

9.3.1 Market Estimates & Forecast, 2020–2027

9.4 Research Centers

9.4.1 Market Estimates & Forecast, 2020–2027

10 Global Delirium Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 U.S.

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 U.K.

10.3.1.4 Italy

10.3.1.5 Spain

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

12 Company Profiles

12.1 Dr. Franz Kohler Chemie GmbH

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 Fraser Health

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Gaia BioPharma Ltd.

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Novartis AG

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Pfizer, Inc.

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.6 Regenstrief Institute, Inc.

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 Air Liquide Sante International.

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Others

13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of the Pharmaceutical Industry

14 Appendix

LIST OF TABLES

Table 1 Delirium Industry Synopsis, 2020–2027

Table 2 Global Delirium Market Estimates & Forecast, 2020–2027, (USD Million)

Table 3 Global Delirium Market, by Region, 2020–2027, (USD Million)

Table 5 Global Delirium Market, by Treatment, 2020–2027, (USD Million)

Table 6 Global Delirium Market, by Diagnosis, 2020–2027, (USD Million)

Table 7 Global Delirium Market, by End-User, 2020–2027, (USD Million)

Table 8 North America Delirium Market, by Treatment, 2020–2027, (USD Million)

Table 9 North America Delirium Market, by Diagnosis, 2020–2027, (USD Million)

Table 10 North America Delirium Market, by End-User, 2020–2027, (USD Million)

Table 11 U.S. Delirium Market, by Treatment, 2020–2027, (USD Million)

Table 12 U.S. Delirium Market, by Diagnosis, 2020–2027, (USD Million)

Table 13 U.S. Delirium Market, by End-User, 2020–2027, (USD Million)

Table 14 Canada Delirium Market, by Treatment, 2020–2027, (USD Million)

Table 15 Canada Delirium Market, by Diagnosis, 2020–2027, (USD Million)

Table 16 Canada Delirium Market, by End-User, 2020–2027, (USD Million)

Table 17 South America Delirium Market, by Treatment, 2020–2027, (USD Million)

Table 18 South America Delirium Market, by Diagnosis, 2020–2027, (USD Million)

Table 19 South America Delirium Market, by End-User, 2020–2027, (USD Million)

Table 20 Europe Delirium Market, by Treatment, 2020–2027, (USD Million)

Table 21 Europe Delirium Market, by Diagnosis, 2020–2027, (USD Million)

Table 22 Europe Delirium Market, by End-User, 2020–2027, (USD Million)

Table 23 Western Europe Delirium Market, by Treatment, 2020–2027, (USD Million)

Table 24 Western Europe Delirium Market, by diagnosis, 2020–2027, (USD Million)

Table 25 Western Europe Delirium Market, by End-User, 2020–2027, (USD Million)

Table 26 Eastern Europe Delirium Market, by Treatment, 2020–2027, (USD Million)

Table 27 Eastern Europe Delirium Market, by diagnosis, 2020–2027, (USD Million)

Table 28 Eastern Europe Delirium Market, by End-User, 2020–2027, (USD Million)

Table 29 Asia Pacific Delirium Market, by Treatment, 2020–2027, (USD Million)

Table 30 Asia Pacific Delirium Market, by diagnosis, 2020–2027, (USD Million)

Table 31 Asia Pacific Delirium Market, by End-User, 2020–2027, (USD Million)

Table 32 Middle East & Africa Delirium Market, by Treatment, 2020–2027, (USD Million)

Table 33 Middle East & Africa Delirium Market, by diagnoses, 2020–2027, (USD Million)

Table 34 Middle East & Africa Delirium Market, by End-User, 2020–2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for the Global Delirium Market

Figure 3 Segmentation Market Dynamics for the Delirium Market

Figure 4 Global Delirium Market Share, by Treatment 2020

Figure 5 Global Delirium Market Share, by Diagnosis 2020

Figure 6 Global Delirium Market Share, by End-User, 2020

Figure 7 Global Delirium Market Share, by Region, 2020

Figure 8 North America Delirium Market Share, by Country, 2020

Figure 9 Europe Delirium Market Share, by Country, 2020

Figure 10 Asia Pacific Delirium Market Share, by Country, 2020

Figure 11 Middle East & Africa Delirium Market Share, by Country, 2020

Figure 12 Global Delirium Market: Company Share Analysis, 2020 (%)

Figure 13 Dr. Franz Kohler Chemie GmbH: Key Financials

Figure 14 Dr. Franz Kohler Chemie GmbH: Segmental Revenue

Figure 16 Dr. Franz Kohler Chemie GmbH: Geographical Revenue

Figure 17 Novartis AG: Key Financials

Figure 18 Novartis AG: Segmental Revenue

Figure 19 Novartis AG: Geographical Revenue

Figure 20 Avicena Inc.: Key Financials

Figure 21 Avicena Inc.: Segmental Revenue

Figure 22 Avicena Inc. Geographical Revenue

Figure 23 Pfizer, Inc.: Key Financials

Figure 24 Pfizer, Inc.: Segmental Revenue

Figure 25 Pfizer, Inc.: Geographical Revenue

Figure 26 Regenstrief Institute: Key Financials

Figure 27 Regenstrief Institute: Segmental Revenue

Figure 28 Regenstrief Institute. Geographical Revenue

Figure 29 Air Liquide Sante International.: Key Financials

Figure 30 Air Liquide Sante International.: Segmental Revenue

Figure 31 Air Liquide Sante International.: Geographical Revenue

Figure 32 Gaia BioPharma Ltd.: Key Financials

Figure 33 Gaia BioPharma Ltd.: Segmental Revenue

Figure 34 Gaia BioPharma Ltd.: Geographical Revenue